GeneThera, Inc. (GTHR)

0.0000 0.0000 (0.00%) At close: 02:14PM EDT

GeneThera, Inc.

3051 West 105th Avenue
Suite 350251
Westminster, CO 80035
United States
720 587 5100
https://www.genethera.net

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 2

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Antonio Milici M.D., Ph.D.	Founder, Chairman, CEO, President & Chief Scientific Officer	258k	N/A	1955
Ms. Tannya L. Irizarry	Chief Administrative Officer, Interim CFO, Secretary & Compliance Officer	208k	N/A	1960

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

GeneThera, Inc., a biotechnology company, develops molecular assays and therapeutics for the detection and treatment of zoonotic diseases. It offers treatments for zoonotic diseases, such as COVID -19 disease; paratuberculosis (Johne's disease) that is in Stage III clinical phase; mad cow and chronic wasting diseases; and E.coli and salmonella infections, as well as develops vaccine for mycobacterium avium sub paratuberculosis bacteria. The company's Molecular Robotic/AI Platform and Therapeutic strategy is designed to prevent the spread of disease from animals and allow to better control of zoonotic infectious agents. GeneThera, Inc. is based in Westminster, Colorado.

Corporate governance

GeneThera, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.